Healthcare

Health Insurance Tax Credit Dispute Triggers Federal Government Shutdown

Health Insurance Tax Credit Dispute Triggers Federal Government Shutdown

The U.S. government shutdown stems from congressional disagreement over expiring Affordable Care Act health insurance tax credits, creating uncertainty for American healthcare costs.

October 3, 2025
AI Technology Addresses Growing DIY Dentistry Crisis in UK

AI Technology Addresses Growing DIY Dentistry Crisis in UK

Artificial intelligence is transforming dental care by addressing the dangerous rise of DIY dentistry practices in the UK while creating new business opportunities across the healthcare technology sector.

October 3, 2025
Alpha Cognition Secures $35 Million in Oversubscribed Public Offering to Accelerate Neurodegenerative Disease Treatment Commercialization

Alpha Cognition Secures $35 Million in Oversubscribed Public Offering to Accelerate Neurodegenerative Disease Treatment Commercialization

Alpha Cognition's successful $35 million public offering will accelerate commercialization of its Alzheimer's treatment ZUNVEYL and advance development of other neurodegenerative disease therapies, addressing critical unmet medical needs.

October 3, 2025
Healthcare Triangle Secures $755,000 Through Warrant Restructuring

Healthcare Triangle Secures $755,000 Through Warrant Restructuring

Healthcare Triangle's strategic warrant restructuring provides immediate capital infusion while positioning the company for future growth through new investor incentives.

October 3, 2025
Medical Affairs AI Immersion Lab Aims to Accelerate Pharmaceutical Industry Adoption

Medical Affairs AI Immersion Lab Aims to Accelerate Pharmaceutical Industry Adoption

Dynamic Global Events is launching a hands-on AI training program for medical affairs professionals to help pharmaceutical companies build business cases and implement artificial intelligence solutions that are already transforming the industry.

October 3, 2025
ORGANA International Marks 30 Years of Wellness Innovation and Plans Expanded U.S. Distribution

ORGANA International Marks 30 Years of Wellness Innovation and Plans Expanded U.S. Distribution

ORGANA International celebrates three decades of natural mineral-based wellness products while preparing for broader U.S. distribution, highlighting the company's customer-focused approach and unique mineral delivery technology.

October 3, 2025
HRO Today Opens Nominations for 2026 Front of the Frontline Awards Amid Healthcare Staffing Crisis

HRO Today Opens Nominations for 2026 Front of the Frontline Awards Amid Healthcare Staffing Crisis

The 2026 HRO Today Front of the Frontline Awards recognize HR leaders addressing critical healthcare workforce challenges including staffing shortages, clinician burnout, and rising labor costs that threaten patient care and sector resilience.

October 3, 2025
Alsco Uniforms Donates $50,000 to Support Homeless Services in San Diego

Alsco Uniforms Donates $50,000 to Support Homeless Services in San Diego

Alsco Uniforms has donated $50,000 to Father Joe's Villages to support critical services for San Diego's homeless population, which exceeds 9,900 people amid record-high homelessness nationwide.

October 3, 2025
New Nursing Guide by Healthcare Entrepreneur Aims to Strengthen Profession and Patient Care

New Nursing Guide by Healthcare Entrepreneur Aims to Strengthen Profession and Patient Care

Nurse Practitioner Lorraine Voltaire's new book "Nursing 101" provides essential guidance for healthcare professionals and families while highlighting nursing's critical role in community health.

October 3, 2025
BioUtah Announces Early Bird Registration for 2025 Utah Life Sciences Summit Featuring Top Federal Regulators

BioUtah Announces Early Bird Registration for 2025 Utah Life Sciences Summit Featuring Top Federal Regulators

BioUtah's upcoming 2025 Utah Life Sciences Summit brings together industry leaders and federal regulators to address critical healthcare innovation challenges in one of the nation's fastest-growing life sciences hubs.

October 2, 2025
DGE to Host 5th Investigator-Initiated Trials Summit in Philadelphia, Addressing Clinical Research Challenges

DGE to Host 5th Investigator-Initiated Trials Summit in Philadelphia, Addressing Clinical Research Challenges

The upcoming 5th Investigator-Initiated Trials Summit in Philadelphia brings together life sciences professionals to address critical challenges in clinical research programs, highlighting the importance of collaborative solutions in advancing medical innovation.

October 2, 2025
Ronald McDonald House Charities Hosts Annual Bandana Ball to Support Families of Critically Ill Children

Ronald McDonald House Charities Hosts Annual Bandana Ball to Support Families of Critically Ill Children

The annual Bandana Ball fundraising event brings the Central Texas community together to support programs that provide essential housing and support services for families with children facing serious medical treatments.

October 2, 2025
Healthcare Triangle Secures $1.63 Million Through Warrant Exercise Agreements

Healthcare Triangle Secures $1.63 Million Through Warrant Exercise Agreements

Healthcare Triangle has secured approximately $1.63 million in immediate funding through warrant exercise agreements with existing investors, providing crucial capital for the company's digital transformation initiatives in the healthcare sector.

October 2, 2025
Four Simple Habits to Strengthen Immune Health During Cold and Flu Season

Four Simple Habits to Strengthen Immune Health During Cold and Flu Season

This article outlines four practical lifestyle habits that can help support natural immune system function and reduce illness risk during cold and flu season.

October 2, 2025
Quantum BioPharma Advances Multiple Sclerosis Treatment Toward Clinical Trials

Quantum BioPharma Advances Multiple Sclerosis Treatment Toward Clinical Trials

Quantum BioPharma has received final toxicity reports for its Lucid-MS drug candidate, clearing a critical regulatory hurdle toward Phase 2 clinical trials for treating multiple sclerosis by targeting demyelination.

October 2, 2025
Nightmare Bacteria Infections Surge in U.S., Prompting Urgent Response from Biotech Sector

Nightmare Bacteria Infections Surge in U.S., Prompting Urgent Response from Biotech Sector

The rapid spread of antibiotic-resistant 'nightmare bacteria' in the United States is driving increased focus on biotech companies developing novel treatments to address this growing public health crisis.

October 2, 2025
OHSU Receives $6.7M NIH Grant to Study Cannabis Effects in HIV-Positive Pregnant Women

OHSU Receives $6.7M NIH Grant to Study Cannabis Effects in HIV-Positive Pregnant Women

Oregon Health and Science University researchers secured substantial federal funding to investigate marijuana's impact on HIV-positive pregnant women, addressing critical gaps in medical cannabis research and maternal health.

October 1, 2025
Lantern Pharma's AI Platform Helps Hoth Therapeutics Accelerate Drug Development

Lantern Pharma's AI Platform Helps Hoth Therapeutics Accelerate Drug Development

Hoth Therapeutics is using Lantern Pharma's PredictBBB.ai platform to streamline drug candidate selection by predicting blood-brain barrier penetration with 94% accuracy, potentially accelerating development of neurological treatments.

October 1, 2025
Medicaid Cuts Threaten Healthcare Access for Millions, Warns Medical Leader

Medicaid Cuts Threaten Healthcare Access for Millions, Warns Medical Leader

Dr. Susan Reynolds warns that proposed federal Medicaid cuts could leave 1.8 million rural residents without coverage and jeopardize hundreds of rural hospitals, representing a moral crisis affecting vulnerable populations.

October 1, 2025
Visory Health Reports $790 Million in Savings on Cardiovascular Medications for 1.5 Million Patients

Visory Health Reports $790 Million in Savings on Cardiovascular Medications for 1.5 Million Patients

Visory Health's prescription discount platform has saved Americans nearly $790 million on critical cardiovascular medications since 2022, addressing cost barriers that prevent patients from accessing life-saving treatments for conditions like high cholesterol.

October 1, 2025
Sapu Nano Receives Australian Ethics Approval for Breast Cancer Drug Trial

Sapu Nano Receives Australian Ethics Approval for Breast Cancer Drug Trial

Sapu Nano's Sapu003, an injectable form of Everolimus using proprietary nanoparticle technology, has received HREC approval for human clinical trials in Australia, potentially offering more effective breast cancer treatment through improved drug delivery.

October 1, 2025
Quantum BioPharma Appoints Leading MS Expert Dr. Jack Antel as Clinical Advisor for Lucid-MS Development

Quantum BioPharma Appoints Leading MS Expert Dr. Jack Antel as Clinical Advisor for Lucid-MS Development

Quantum BioPharma has strengthened its multiple sclerosis program by appointing renowned neurologist Dr. Jack Antel to guide the clinical development of Lucid-21-302 as the investigational drug advances toward Phase 2 trials.

October 1, 2025
Soligenix Secures $7.5 Million Financing to Advance Rare Disease Pipeline Through 2026

Soligenix Secures $7.5 Million Financing to Advance Rare Disease Pipeline Through 2026

Soligenix has closed a $7.5 million public offering that extends its financial runway through 2026, providing critical funding to advance multiple late-stage rare disease treatments including its cutaneous T-cell lymphoma therapy HyBryte™.

October 1, 2025
American Heart Association Acquires Cardiometabolic Center Alliance to Advance Integrated Care Model

American Heart Association Acquires Cardiometabolic Center Alliance to Advance Integrated Care Model

The American Heart Association's acquisition of the Cardiometabolic Center Alliance program assets represents a significant advancement in integrated care for cardiovascular, kidney, and metabolic conditions, potentially transforming treatment approaches for millions of patients.

October 1, 2025
GeoVax Sponsors 2025 Global Health Equity Summit to Advance Vaccine Access

GeoVax Sponsors 2025 Global Health Equity Summit to Advance Vaccine Access

GeoVax's sponsorship of the Dr. David Satcher Global Health Equity Summit highlights the biotechnology company's commitment to ensuring equitable global access to vaccines and therapies, particularly for immunocompromised and underserved populations.

October 1, 2025
NYU's Judith Hochman to Receive 2025 Research Achievement Award for Transformative Cardiology Research

NYU's Judith Hochman to Receive 2025 Research Achievement Award for Transformative Cardiology Research

Dr. Judith Hochman's recognition by the American Heart Association highlights her pivotal clinical trials that have reshaped global cardiology guidelines and improved patient outcomes in ischemic heart disease.

October 1, 2025
National Survey Reveals Nearly Half of Americans Suffer From Unexplained Pain and Illness

National Survey Reveals Nearly Half of Americans Suffer From Unexplained Pain and Illness

A new national survey shows that 48% of Americans experience unexplained chronic pain or illness, highlighting the urgent need for greater awareness and access to neuroplastic treatments that could transform healthcare outcomes.

October 1, 2025
New Jersey Law Firm Launches #EmployersThinkPink Initiative to Promote Breast Cancer Screening Through Paid Time Off

New Jersey Law Firm Launches #EmployersThinkPink Initiative to Promote Breast Cancer Screening Through Paid Time Off

A New Jersey personal injury law firm has launched the #EmployersThinkPink initiative, encouraging companies nationwide to provide paid time off for mammograms, highlighting how corporate policies can significantly impact early breast cancer detection and employee health outcomes.

October 1, 2025
Lauderdale County Jury Awards $7 Million in Medical Negligence Case Against Radiologist

Lauderdale County Jury Awards $7 Million in Medical Negligence Case Against Radiologist

A Lauderdale County jury awarded $7 million to local dentist Sunitha Madasu after finding radiologist Donald J. Bowling and Lauderdale Radiology Group negligent for failing to identify a blood clot on her CT scan, leading to permanent brain injuries that could have been prevented with proper diagnosis.

October 1, 2025
FDA Guidance Accelerates Lantern Pharma's Pediatric Brain Cancer Therapy Development

FDA Guidance Accelerates Lantern Pharma's Pediatric Brain Cancer Therapy Development

Lantern Pharma received FDA guidance that will help advance its LP-184/STAR-001 therapy for rare pediatric brain cancers toward clinical trials planned for 2026, representing significant progress in treating conditions with limited options.

September 30, 2025
PreviousPage 37 of 92Next